Compare NEU & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEU | STVN |
|---|---|---|
| Founded | 1887 | 1949 |
| Country | United States | Italy |
| Employees | 2060 | N/A |
| Industry | Major Chemicals | Containers/Packaging |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 5.4B |
| IPO Year | N/A | 2021 |
| Metric | NEU | STVN |
|---|---|---|
| Price | $595.15 | $16.03 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $23.75 |
| AVG Volume (30 Days) | 154.1K | ★ 1.0M |
| Earning Date | 02-11-2026 | 03-05-2026 |
| Dividend Yield | ★ 2.02% | 0.40% |
| EPS Growth | N/A | ★ 19.61 |
| EPS | ★ 44.44 | 0.60 |
| Revenue | ★ $2,725,169,000.00 | $1,373,219,524.00 |
| Revenue This Year | N/A | $8.42 |
| Revenue Next Year | N/A | $9.61 |
| P/E Ratio | ★ $13.34 | $26.78 |
| Revenue Growth | N/A | ★ 6.97 |
| 52 Week Low | $510.07 | $13.91 |
| 52 Week High | $875.97 | $28.00 |
| Indicator | NEU | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 28.49 | 41.40 |
| Support Level | $711.67 | $15.06 |
| Resistance Level | $734.52 | $16.69 |
| Average True Range (ATR) | 24.49 | 1.06 |
| MACD | -5.95 | 0.15 |
| Stochastic Oscillator | 1.77 | 50.24 |
NewMarket Corp is a holding company that, through its subsidiaries, manufactures and sells petroleum additives used in lubricating oils and fuels to enhance performance. The company operates through two segments: petroleum additives, mainly represented by Afton, where lubricant additives improve the efficiency and durability of base fluids and fuel additives help meet fuel specifications and improve fuel performance, and specialty materials, represented by AMPAC and Calca, including the antiknock compounds business of Ethyl, where primary raw materials include electricity, sodium chlorate, ammonia, chlorine, caustic, and hydrochloric acid, with graphite used in electrolytic cells. The company has operations in North America, Latin America, Asia Pacific, and EMEAI regions.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.